BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25957891)

  • 1. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
    Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
    Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia.
    Fernandes AT; Rocha NP; Vendrame E; Russomano F; Grinsztejn BJ; Friedman RK; Pinto AC; Klumb EM; Avvad E; Macedo J; Martínez-Maza O; Bonecini-Almeida Mda G
    Apoptosis; 2015 Oct; 20(10):1347-57. PubMed ID: 26272263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; Cintra ML; Moraes AM; Lima CS
    J Dermatol Sci; 2014 May; 74(2):135-41. PubMed ID: 24461648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of
    Al-Zubaidy HFS; Majeed SR; Al-Koofee DAF
    Arch Razi Inst; 2022 Apr; 77(2):799-808. PubMed ID: 36284943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.
    Agostini LP; Stur E; Garcia FM; Ventorim DP; Dos Reis RS; Dettogni RS; Dos Santos EVW; Peterle GT; Maia LL; Mendes SO; de Carvalho MB; Tajara EH; de Paula F; Dos Santos M; da Silva AMA; Louro ID
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):727-735. PubMed ID: 29135311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
    Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
    Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development.
    Cingeetham A; Vuree S; Jiwatani S; Kagita S; Dunna NR; Meka PB; Gorre M; Annamaneni S; Digumarti R; Sinha S; Satti V
    Asian Pac J Cancer Prev; 2015; 16(7):2707-12. PubMed ID: 25854351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia.
    Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Sadegh MH; Nematollahi MH; Rezaei M; Rasouli A; Eskandari F; Heydarabad MZ; Teimoori B; Salimi S
    Apoptosis; 2019 Apr; 24(3-4):301-311. PubMed ID: 30701356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
    Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
    Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
    Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
    Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population.
    Li W; Qian C; Wang L; Teng H; Zhang L
    Tumour Biol; 2014 Mar; 35(3):2259-64. PubMed ID: 24287948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
    Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
    Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (
    Moawadh MS; Mir R; Tayeb FJ; Asim O; Ullah MF
    Curr Issues Mol Biol; 2023 May; 45(5):3933-3952. PubMed ID: 37232720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.
    Moschos MM; Chatziralli I; Brouzas D; Gazouli M
    Ophthalmic Res; 2017; 58(4):227-230. PubMed ID: 28877516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
    Mehta SV; Shukla SN; Vora HH
    Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.